AdCOV‑19
COVID‑19
Phase 1/2Active
Key Facts
About Adimmune
Taiwanese biotech delivering rapid, adjuvant‑enhanced subunit vaccines for emerging infectious diseases.
View full company profileTherapeutic Areas
Other COVID‑19 Drugs
| Drug | Company | Phase |
|---|---|---|
| SpikoGen® / Covax‑19 | Vaxine | Commercial |
| P-004 | Panacea Biotec | Phase 3 |
| FAVILOW | MSN Laboratories | Commercial |
| Movfor (Molnupiravir) | Hetero | Phase 3 |
| Nirmatrelvir/Ritonavir Generic | Hetero | Commercial |
| Oravax | Premas Biotech | Preclinical |
| SARS‑CoV‑2 Detection (TRURAPID®) | 3B BlackBio | Commercial |
| CPR‑COV‑001 | Chugai Pharmabody Research | Preclinical |
| Antroquinonol (Hocena) | Golden Biotechnology | Phase 1/2 |